Compounds based on 3- or 5-biphenyl-4-ylisoxazole useful for the treatment of fibrosis, pain, cancer, and respiratory, allergic, nervous system or cardiovascular disease
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.リゾフォスファジチン酸受容体のアンタゴニストである化合物が本明細書に記載される。LPA依存性またはLPA介在性障害または疾患を治療するための、本明細書に記載の化合物を含む医薬組成物および医薬、ならびにこのようなアンタゴニストを単独で、または他の化合物と組み合わせて使用する方法もまた記載される。